1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographics and diagnoses of the pediatric age group tabulated as NDN versus HDNa
Variable/Group NDN (n = 5) (%) HDN (n = 15) (%) Race (white versus nonwhite) 3 W (100) 11 W (73), 4 NW (27) Sex (female vs male) 3 F (60), 2 M (40) 5 F (33), 10 M (67) Total RT dose mean (SD) (cGy) 5628 (222) 5196 (680) Anaplastic astrocytoma 1 (20.0) 1 (6.7) Astrocytoma 0 (0.0) 3 (20.0) Astrocytoma, pilocytic 1 (20.0) 2 (13.3) Desmoplastic nodular medulloblastoma 0 (0.0) 1 (6.7) Ependymoma 1 (20.0) 2 (13.3) Glioma, malignant 1 (20.0) 0 (0.0) Medulloblastoma 1 (20.0) 5 (33.3) Primitive neuroectodermal tumor 0 (0.0) 1 (6.7)
Note:—W indicates white; NW, nonwhite.
↵a Note a significantly higher HDN percentage compared with the adult population.